300026 红日药业
2024/06 - 中期2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)1.6965.9607.7739.1848.203
总资产报酬率 ROA (%)1.2434.1375.1456.3096.164
投入资产回报率 ROIC (%)1.4214.8146.0757.4697.300

边际利润分析
销售毛利率 (%)52.94654.10957.72757.93356.541
营业利润率 (%)5.4848.00910.71511.41010.082
息税前利润/营业总收入 (%)6.32110.68211.57711.87211.447
净利润/营业总收入 (%)5.0948.2119.3428.7468.626

收益指标分析
经营活动净收益/利润总额(%)112.77985.741102.181121.848103.652
价值变动净收益/利润总额(%)-0.726-0.2310.441-2.6910.296
营业外收支净额/利润总额(%)3.28719.3730.538-2.4604.287

偿债能力分析
流动比率 (X)4.1034.2952.7583.3072.442
速动比率 (X)2.9763.0411.9312.6731.836
资产负债率 (%)25.72625.07233.15431.4880.274
带息债务/全部投入资本 (%)14.22514.77420.58720.04114.453
股东权益/带息债务 (%)588.975567.423377.808391.990584.922
股东权益/负债合计 (%)283.466293.538197.508212.669258.061
利息保障倍数 (X)9.71214.27714.38316.13012.528

营运能力分析
应收账款周转天数 (天)168.145179.592186.193144.908130.465
存货周转天数 (天)246.078268.047225.278151.834147.432